FINDINGS OF SCIENTIFIC MISCONDUCT

RELEASE DATE:  December 9, 2003

NOTICE:  NOT-OD-04-014

Department of Health and Human Services (DHHS)

Notice is hereby given that the Office of Research Integrity (ORI) and the 
Assistant Secretary for Health have taken final additional action in the 
following case:

Kuei-Fu (Tom) Lin, D.V.M., Medical University of South Carolina (MUSC):  
Based on the report of an investigation conducted by MUSC and additional 
analysis conducted by ORI in its oversight review, the U.S. Public Health 
Service (PHS) found on June 12, 2001, that Dr. Lin, a former graduate 
student, Department of Biochemistry and Molecular Biology at MUSC, engaged in 
scientific misconduct in research supported by the National Heart, Lung, and 
Blood Institute (NHLBI), National Institutes of Health (NIH), grants R01 
HL29397,  Regulation and Function of Renal Kallikrein,  and R01 HL56686, 
 Gene Therapy in Experimental Hypertension and Renal Diseases,  by falsifying 
data published in publications in Hypertension 26:847-853, 1995, Hypertension 
Research 20:269-277, 1997, and Human Gene Therapy 9:1429-1438, 1998.

Subsequent to the execution of a three-year Voluntary Exclusion Agreement 
(Agreement), Dr. Lin continued to receive PHS funds through April 30, 2003, 
in material violation of the Agreement.  Based on Dr. Lin’s aforementioned 
violation, and in lieu of initiation of debarment proceedings authorized by 
45 C.F.R.   76.305(c)(4) for Dr. Lin’s violation of a material provision of 
the Agreement, the parties have agreed to extend the term of Dr. Lin’s 
voluntary exclusion through April 29, 2007.

INQUIRIES

For further information contact:

Director
Division of Investigative Oversight
Office of Research Integrity
1101 Wootton Parkway, Suite 750
Rockville, MD  20852
Telephone:  301-443-5330

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

			Department of Health and Human Services (HHS)
NIH... Turning Discovery Into Health®